|
Mar 27
|
The 7 Best Penny Stocks to Buy in Q2 2024
|
|
Mar 26
|
Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks
|
|
Mar 19
|
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
|
|
Mar 11
|
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
|
|
Mar 5
|
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
|
|
Feb 1
|
Techne (TECH) Q2 Earnings and Revenues Lag Estimates
|
|
Jan 30
|
Baillie Gifford Adjusts Stake in AbCellera Biologics Inc
|
|
Jan 23
|
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
|
|
Jan 15
|
3 Growth Stocks That Could Go Parabolic in 2024
|
|
Jan 3
|
Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year?
|
|
Dec 20
|
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
|
|
Nov 24
|
AbCellera Biologics Insiders Added US$2.47m Of Stock To Their Holdings
|
|
Nov 16
|
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
|
|
Nov 3
|
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
|
|
Nov 3
|
AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Q3 2023 Abcellera Biologics Inc Earnings Call
|
|
Nov 3
|
Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress
|
|
Nov 3
|
AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
AbCellera Biologics Inc (ABCL) Reports Q3 2023 Earnings: Revenue Drops to $7 Million
|
|
Nov 2
|
AbCellera Reports Q3 2023 Business Results
|